Fulcrum Therapeutics (FULC) Q3 2023 Earnings

7NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.5
-0.46
-0.42
-0.38

Details

Expected EPS
-0.44
Actual EPS
-0.39
Surprise EPS
0.05
Surprise Percent
+11.36%

Description

Fulcrum Therapeutics (FULC) has reported earnings of -0.39 per share for Q3 2023.

0 Comments

Share your thoughts